摘要
目的评价不同他汀类药物治疗早发冠心病急性心肌梗死(acute myocardial infarction,AMI)患者近期疗效。方法 A组(n=41)、B组(n=47)分别采用瑞舒伐他汀、阿托伐他汀治疗,对比近期疗效指标。结果治疗后,A组与B组hs-CRP、TG低于治疗前,A组hsCRP低于B组,6个月内,A组心血管事件发生率7.32%低于B组29.79%,差异具有统计学意义(P<0.05)。结论瑞舒伐他汀治疗早发冠心病AMI疗效优于阿托伐他汀。
Objective To evaluate the short-term effect of acute myocardial infarction（AMI）in the treatment of premature coronary heart disease（myocardial）. Methods Group A（n=41）,group B（n=47） were treated by rosuvastatin and atorvastatin respectively,the comparison of the short-term curative effect. Results After treatment,hs-CRP and TG of two groups were lower than before treatment,hs-CRP of group A was lower than Group B. In 6 months,cardiovascular events of group A was lower than that of group B（29.79%）,the difference was statistically significant（P〈0.05）. Conclusion The efficacy of AMI in the treatment of premature coronary heart disease is better.
出处
《中国卫生标准管理》
2015年第32期130-132,共3页
China Health Standard Management
关键词
早发冠心病
急性心肌梗死
他汀类药物
心血管事件
Premature coronary heart disease
Acute myocardial infarction
Statins
Cardiovascular events
